Breast Cancer Frei Flashcards Preview

Oncology > Breast Cancer Frei > Flashcards

Flashcards in Breast Cancer Frei Deck (22):
1

Which of the following are risk factors of breast cancer that CANNOT be changed? (Select All)

A. Age

B. Obesity

C. Exercise

D. Radiation

E. Treatment with DES

A. Age

D. Radiation

E. Treatment with DES

DES was used back then to treat pregnant women with recurrent nausea. 

2

Which of these patients has the unchangeable risk factor of radiation therapy?

A. MJ who received radiation therapy for a femoral lymphoma

B. BC who received radiiation therapy for a cranial lymphoma

C. PP who received radiation therapy in the pectoral region

D. CJ who received radiation therapy for a cervical lymphoma

C. PP who received radiation therapy in the sternal area

Radiation treatment is only considered an unchangeable risk factor if it has occurred in the area of the breast tissue. 

3

Which of these is considered an unchangeable risk factor for the development of breast cancer? (select all)

A. Family/Personal history of breast cancer

B. Race

C. Menstrual History

D. Not having children

E. Reproductive history

A. Family/Personal history of breast cancer

B. Race

C. Menstrual History

E. Reproductive history

4

The unchangeable risk factor of Menstrual history applies to which of the following patients? (Select All)

A. CA, female who began menstruating sometime between the age of 14-15

B. TA, female who began menstruating sometime between the age of 9-10

C. AT, female who began menopause sometime between the age of 40-41

D. CC, female who began menopause sometime between the age of 56-57

B. TA, female who began menstruating sometime between the age of 9-10

D. CC, female who began menopause sometime between the age of 56-57

Females who have begun menstruation at an early age of 9-10 are at an increased risk of developing breast cancer.

Females who are continuing to menstruate beyond the age of 55 are at an increased risk of developing breast cancer. In other words females who have not begun menopause at least before the age of 55.

5

The unchangeable risk factor of Reproductive History applies to which of the following patients? 

A. MJ, who gave birth to her first child at the age of 23

B. TC, who gave birth to her first child at the age of 18

C. LA, who gave birth to her first child at the age of 29

D. PP, who gave birth to her first child at the age of 31

D. PP, who gave birth to her first child at the age of 31

Females who gave birth before the age of 25= Decreased risk

Females who gave birth between the age of 25-30= Neutral risk

Females who gave birth after the age of 30= Increased risk 

6

T/F

People of Ashkenazi Jewish descent are at an increased risk of developing breast cancer

True

This was a random fact that she pointed out that she related to the unchangeable risk factor Race

7

Which of the following are Risk Factors for breast cancer that can be controlled? (select all)

A. Obesity 

B. Exercise

C. Not having children

D. Use of birth control pills

E. Genetics

A. Obesity

B. Exercise

C. Not having children

D. Use of birth control pills

8

Which of the following is a controllable risk factor for the development of breat cancer?

A. Genetics

B. Reproductive history

C. Hormone Replacement Therapy

D. Menstrual history

E. Age

C. Hormone Replacement therapy

9

Which of these women is affected by the controllable risk factor of obesity? (select all)

A. CJ, 42 yo obese female who is premenopausal

B. TJ, 40 yo obese female who is postmenopausal 

C. LA, 46 yo obese female who is postmenopausal

D. TT, 44 yo obese female who is premenopausal

B. TJ, 40 yo obese female who is postmenopausal 

C. LA, 46 yo obese female who is postmenopausal

Women who are postmenopausal and obese are at an increased risk of breast cancer

Women who are obese but are premenopausal are not at an increased risk of breast cancer

10

T/F

The controllable risk factor of Hormone Replacement Therapy is seen in women who are on Premarin (estrogen-progestin combination) 

True

This was proven by the womens health initiative 

11

Which of the following patients has the controllable risk factor of birth control use?

A. CA, female who has recently stopped the use of her birth control pills

B. TA, female who is currently taking birth control

C. TT, female who has been prescribed birth control pills but has stopped taking within the past week

D. CC, female who has a history of taking multiple types of birth control but has stopped within the past month. 

B. TA, female who is currently taking birth control

The increased risk of breast cancer only applies to patients who are currently taking birth control. 

12

Which of the following is true regarding Tamoxifen? (Select All)

A. Indicated for breast cancer prevention

B. Reduction in breast cancer incidence of 30-40%

C. Tamoxifen was shown to be inferior to Raloxifene in trials for prevention of breast cancer

D. Tamoxifen was shown to have a much lower incidence of blood clots in comparison to Raloxifene

A. Indicated for breast cancer prevention

B. Reduction in breast cancer incidence of 30-40%

13

Which of the following statements is true when comparing Tamoxifen to Raloxifene? (Select All)

A. Tamoxifen was shown to have a much smaller side effect profile in comparison to Raloxifene

B. Tamoxifen was shown to have a higher incidence of endometrial (uterine) cancer

C. Tamoxifen was proven to have a better reduction in breast cancer occurance than Raloxifene

D. Tamoxifen was shown to have a higher incidence of side effects such as cataracts. 

E. Both Tamoxifen and Raloxifene were shown to cause blood clots (DVT)

B. Tamoxifen was shown to have a higher incidence of endometrial (uterine) cancer

C. Tamoxifen was proven to have a better reduction in breast cancer occurance than Raloxifene

D. Tamoxifen was shown to have a higher incidence of side effects such as cataracts. 

E. Both Tamoxifen and Raloxifene were shown to cause blood clots (DVT)

14

T/F

Exemestane and Anastrozole (Aromatase inhibitors) were also shown to decrease incidence of breast cancer development.

True

15

Which of these medications is FDA approved for the prevention of 

16

17

18

19

20

21

22